R B Reinhold1. 1. Department of Surgery, Hospital of St Raphael, New Haven, CT 06511.
Abstract
OBJECTIVE: Morbid obesity (excess body weight of 45.5 kg or 100% over ideal body weight) is associated with > 3-fold increased mortality in men and women and is resistant to dietary intervention. Gastric bypass (GBP) and vertical banded gastroplasty (VBG) are the currently accepted surgical treatments. The purpose of this study was to analyze retrospectively 153 consecutive morbidly obese patients who underwent GBP from 1975-1986 and were followed for a minimum of 5 years. METHODS: Data were analyzed from 1-16 years postoperative comparing preoperative morbidity, operative complications, postoperative morbidity, interval weight loss, maximum weight loss, and weight regain. RESULTS: At the 1- and 5-year intervals, 129 and 86 patients respectively were available for review. Operative mortality was < 1%. Weight loss at 1 year = 48.5 kg rising to 57 kg at 24 months. Statistically significant weight loss of 37.0 kg (19.2 SD)(p < .001) was achieved at 5 years. The mean percent excess body weight lost was 66.4 and 50.9% at 1 and 5 years, respectively. No obesity-related deaths occurred in the follow-up period. Incidence of hypertension, cardiac disease and diabetes was reduced by 25-50% during follow-up. CONCLUSIONS: GBP is a safe and effective operation which achieves sustained weight loss of > 35 kg at 5 years and reduces the complications of morbid obesity.
OBJECTIVE: Morbid obesity (excess body weight of 45.5 kg or 100% over ideal body weight) is associated with > 3-fold increased mortality in men and women and is resistant to dietary intervention. Gastric bypass (GBP) and vertical banded gastroplasty (VBG) are the currently accepted surgical treatments. The purpose of this study was to analyze retrospectively 153 consecutive morbidly obesepatients who underwent GBP from 1975-1986 and were followed for a minimum of 5 years. METHODS: Data were analyzed from 1-16 years postoperative comparing preoperative morbidity, operative complications, postoperative morbidity, interval weight loss, maximum weight loss, and weight regain. RESULTS: At the 1- and 5-year intervals, 129 and 86 patients respectively were available for review. Operative mortality was < 1%. Weight loss at 1 year = 48.5 kg rising to 57 kg at 24 months. Statistically significant weight loss of 37.0 kg (19.2 SD)(p < .001) was achieved at 5 years. The mean percent excess body weight lost was 66.4 and 50.9% at 1 and 5 years, respectively. No obesity-related deaths occurred in the follow-up period. Incidence of hypertension, cardiac disease and diabetes was reduced by 25-50% during follow-up. CONCLUSIONS: GBP is a safe and effective operation which achieves sustained weight loss of > 35 kg at 5 years and reduces the complications of morbid obesity.
Authors: S Sauerland; L Angrisani; M Belachew; J M Chevallier; F Favretti; N Finer; A Fingerhut; M Garcia Caballero; J A Guisado Macias; R Mittermair; M Morino; S Msika; F Rubino; R Tacchino; R Weiner; E A M Neugebauer Journal: Surg Endosc Date: 2004-12-02 Impact factor: 4.584
Authors: Daniel Munoz; Eunice Y Chen; Sarah Fischer; Lisa Sanchez-Johnsen; Megan Roherig; Maureen Dymek-Valentine; John C Alverdy; Daniel Le Grange Journal: Eat Disord Date: 2010 Jul-Aug Impact factor: 3.222
Authors: Attila Csendes; Patricio Burdiles; Karin Papapietro; Juan Carlos Diaz; Fernando Maluenda; Ana Burgos; Jorge Rojas Journal: J Gastrointest Surg Date: 2005-01 Impact factor: 3.452
Authors: Juan A Luján; M Dolores Frutos; Quiteria Hernández; Ramón Liron; Jose R Cuenca; Graciela Valero; Pascual Parrilla Journal: Ann Surg Date: 2004-04 Impact factor: 12.969
Authors: Ahmed R Ahmed; Gretchen Rickards; Deb Coniglio; Yinglin Xia; Joseph Johnson; Thad Boss; William O'Malley Journal: Obes Surg Date: 2008-08-30 Impact factor: 4.129